WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2005-2014) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. The report also offers a first-time look at the degree of collaboration across the industry’s clinical pipeline. “Accessing capital and forming strategic allian
| < Prev | Next > |
|---|
